Skip to main content

bamlanivimab and etesevimab User Reviews & Ratings

bamlanivimab and etesevimab has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.

Write a review

  • Cov...
  • Taken for less than 1 month
  • July 29, 2022

For COVID-19 "I was on day 7 of COVID with mild symptoms, and 2 hours after I received the monoclonals, my heart rate spiked, and I went to the hospital. I had a massive inflammatory response. I developed pericarditis and costochondritis. It’s now 7 months later, and I am still having significant heart problems and now have heart disease."

1 / 10
Was this helpful?YesNo
2 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

More about bamlanivimab and etesevimab (bamlanivimab / etesevimab)

Patient resources

Professional resources

Related treatment guides